Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temsirolimus with Cisplatin and Gemcitabine in Advanced Urothelial Cancer
NCT01090466Phase 2Completed
- Sponsor
- Cardiff University
- Start
- Feb 2008
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of temsirolimus in transitional cell carcinoma of the urothelium (TCC), sponsored by Cardiff University. Primary endpoints: Safety profile (DLTs and MTD) and Progression-Free Survival at 6 months. Started Feb 2008; status: completed.
02
Drugs
temsirolimus
03
Conditions
transitional cell carcinoma of the urothelium (TCC)
Beyond the preview
Go deeper on NCT01090466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01090466.